Joel D. Sendek

Joel D. Sendek

Director of Finance/CFO at PERSPECTIVE THERAPEUTICS, INC.
59 year
Finance
Health Technology
Consumer Services

Profile

Joel D.
Sendek
currently works at Perspective Therapeutics, Inc., as Chief Financial Officer from 2025.
Mr. Sendek also formerly worked at Stifel Financial Corp., as Managing Director-Healthcare Equity Research from 2012 to 2014, Progenics Pharmaceuticals, Inc., as Senior Director from 1992 to 1996, Lazard, Inc., as Managing Director, Stifel, Nicolaus & Co., Inc., as Managing Director & Head of Equity Research from 2012 to 2014, FM Partners Holdings LLC, as Managing Director & Senior Analyst in 2011, Goldman Sachs & Co. LLC, as Principal in 1991, Gerard Klauer Mattison & Co., Inc., as Analyst, Forward Pharma A, as CFO & Principal Accounting Officer from 2014 to 2017, Spero Therapeutics, Inc., as CFO, Treasurer & Chief Accounting Officer from 2017 to 2019, and Forward Pharma USA, LLC, as Chief Financial Officer.
Mr. Sendek received his undergraduate degree in 1989 from William Marsh Rice University.

Joel D. Sendek active positions

CompaniesPositionStart
PERSPECTIVE THERAPEUTICS, INC. Director of Finance/CFO 2025-09-03

Former positions of Joel D. Sendek

CompaniesPositionEnd
SPERO THERAPEUTICS, INC. Director of Finance/CFO 2019-11-07
FORWARD PHARMA A/S Director of Finance/CFO 2017-04-29
Analyst-Equity 2014-06-30
STIFEL FINANCIAL CORP. Chief Tech/Sci/R&D Officer 2014-06-30
Analyst-Equity 2011-12-30
See the detail of Joel D. Sendek's experience

Training of Joel D. Sendek

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Finance

Health Technology

Finance

Finance

Finance

Consumer Services

Finance

Finance

Health Technology

Health Technology

Forward Pharma USA, LLC

Health Technology

  1. Stock Market
  2. Insiders
  3. Joel D. Sendek
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!